Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000821995-13-000026
Filing Date
2013-05-09
Accepted
2013-05-08 18:02:40
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2013q110q.htm 10-Q 525251
2 EXHIBIT a2013q1ex-311.htm EX-31.1 9057
3 EXHIBIT a2013q1ex-312.htm EX-31.2 9274
4 EXHIBIT a2013q1ex321.htm EX-32.1 6286
5 EXHIBIT a2013q1ex322.htm EX-32.2 6568
  Complete submission text file 0000821995-13-000026.txt   3851082

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbrx-20130331.xml EX-101.INS 473656
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbrx-20130331.xsd EX-101.SCH 33196
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbrx-20130331_cal.xml EX-101.CAL 61038
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbrx-20130331_def.xml EX-101.DEF 181497
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbrx-20130331_lab.xml EX-101.LAB 389393
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbrx-20130331_pre.xml EX-101.PRE 228969
Mailing Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039
Business Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 9739943999
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 13825896
SIC: 2834 Pharmaceutical Preparations